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TRIM proteins are ubiquitin E3 ligases known to be involved in a number of different processes 
in the cells, such as intracellular signaling, transcription, autophagy, innate immunity, cell cycle 
progression and DNA repair. Mutations and dysregulation of TRIM proteins are implicated in 
many diseases, and a number of TRIMs are described as both tumor suppressors and oncogenes. 
Furthermore, several TRIM proteins are found to have roles in autophagy.  
 We identified TRIM32 as a potential autophagic substrate in a double- tag screen 
including 22 different TRIM proteins. We found that the autophagic degradation of TRIM32 
was selective, and that TRIM32 interacted directly with the autophagy receptors p62 and 
NDP52, either of which was sufficient for directing TRIM32 to lysosomal degradation. 
Conversely, we identified both p62 and NDP52 to be TRIM32 substrates. Mutations in the C-
terminal region of TRIM32 causes limb girdle muscular dystrophy 2H (LGMD2H). The 
LGMD2H disease mutants were unable to ubiquitylate p62 and NDP52, and unable to undergo 
autophagic degradation. Moreover, we showed that reintroduction of TRIM32 in TRIM32 KO 
cells decreased the protein level of the sequestosome-like receptors (SLRs), while 
reintroduction of TRIM32 LGMD2H disease mutant did not. Furthermore, we found TRIM32 
expression in TRIM32 KO cells to enhance ULK1 stability and TBK1 autophosphorylation, 
while the LGMD2H mutant did not. The positive effect of TRIM32 on selective autophagy was 
supported by the finding that mitophagy was reduced in TRIM32 KO cells, while it was restored 
when TRIM32 was reintroduced. These findings suggest that the pathogenic effect of the 
LGMD2H mutation at least partially may be due to dysregulation of selective autophagy 
receptors, affecting the protein homeostasis in muscle cells. 
 We also identified TRIM27 as an autophagy substrate. Similarly as TRIM32, TRIM27 
interacted with p62 and NDP52, and its autophagic degradation was dependent on ATG7 and 
the SLRs. TRIM27 impaired the normal autophagic response of p62 and LC3B when the cells 
were stressed with plasmid transfection or mimicking of virus transfection. Interestingly, 
TRIM27 mRNA was significantly upregulated in breast cancer tissues compared to normal 
tissue, and the expression of TRIM27 in various breast cancer cell lines was inversely correlated 
with LC3B expression. These results may reveal a link between TRIM27 and dysregulated 
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Cells require amino acids, lipids and carbohydrates to stay healthy, and therefore they are 
depending on nutrient uptake and recycling. Furthermore, the cells have to dispose of damaged 
or otherwise unwanted proteins. The maintenance of the proteome is called proteostasis and it 
involves the control of the initial production and folding of the proteins, conformational 
maintenance, control of the abundance and subcellular localization and the disposal of proteins 
by degradation (Klaips et al., 2018). Each process in the cells is carefully watched by the cells 
many quality control systems which makes sure that abnormal mRNA will be degraded before 
translation and misfolded proteins are directed to degradation by chaperones (McClellan et al., 
2005; Shyu et al., 2008). Faults in the proteostasis often results in an accumulation of damaged 
or misfolded proteins, which in turn can cause diseases.   
There are two major pathways for protein turnover, the autophagy/lysosome system and 
the ubiquitin proteasome system (UPS).         
 
Ubiquitin Proteasome system 
Misfolded, damaged and redundant proteins destined for degradation are marked with 
ubiquitin, a 76 amino acid protein, in a process called ubiquitylation. Ubiquitin is a marker for 
many processes, and proteins marked with ubiquitin chains are directed to the proteasome for 
degradation (Chau et al., 1989). Ubiquitylation of proteins involves an E1 ubiquitin-activating 
enzyme, which activate ubiquitin and transfers it to E2 ubiquitin-conjugating enzymes. E3 
ubiquitin-protein ligases specifically binds substrate proteins and E2s, and ubiquitin is then 
transferred from the E2 to the substrates (Figure 1) (Hershko and Ciechanover, 1998; Scheffner 
et al., 1995). E1 enzymes are encoded by two different genes, E2 by at least 37 different genes 
and E3 ligases by more than 800 genes and elicit the specificity of the ubiquitylation process. 
E3 ligases are classified depending on their catalytic site. Really Interesting New Gene (RING) 
ligases simultaneously binds E2 and substrate (Dou et al., 2012; Plechanovova et al., 2012), 
while Homologous to E6AP C-terminus (HECT) and RING-between-RING (RBR) ligases 
receive ubiquitin from E2 before modifying the substrate (Figure 1) (Buetow and Huang, 2016; 
Scheffner et al., 1995; Wenzel et al., 2011). Successive rounds of E3-catalyzed reactions can 
produce substrates with polyubiquitin chains linked to them.  
Ubiquitin itself can be ubiquitylated on seven lysine residues (K6, K11, K27, K29, K33, 




signaling and the fate of the protein (Buetow and Huang, 2016). Initially, polyubiquitylation of 
K48- linked chains was found to target proteins for proteasomal degradation (Chau et al., 1989). 
However, later studies have found that also K11- and K63- linked ubiquitin chains might target 
proteins for proteasomal degradation (Saeki et al., 2009; Xu et al., 2009). Additionally, K11-
linked ubiquitin chains have a role in cell cycle regulation (Jin et al., 2008; Matsumoto et al., 
2010). K6- linkage is involved in regulation of mitophagy (Durcan et al., 2014) and K6- and 
K33- linked polyubiquitylation increase upon DNA damage, indicating that they have a 
signaling role in DNA damage response (Elia et al., 2015). K27- linked polyubiquitylation is 
recently reported to have a role in innate immunity response (Wu et al., 2019) while K29- linked 
polyubiquitin is involved in stimulation of the nuclear factor kappa light chain enhancer of 
activated B cells (NF-B) activation (Huang and Baek, 2017). K63- linked polyubiqutin chains 
confer non-degradative signals for different pathways, for example protein trafficking, ion 
transport, translation and DNA repair (Back et al., 2019; Liu et al., 2018). However, K63- linked 
polyubiquitylation is also associated with degradation by autophagy (Tan et al., 2008). 
Furthermore, the linear ubiquitin chain assembly complex (LUBAC) is a ubiquitin 
ligase complex composed of two RING finger proteins which does not form lysine linkages, 
but linkages between the C- and N-termini of ubiquitin (Kirisako et al., 2006). LUBAC 
activates canonical NF-B by binding NF-B essential modulator (NEMO), and it conjugates 
linear polyubiquitin chains onto specific lysine residues in NEMO (Tokunaga et al., 2009).  
 
 
Figure 1: Ubiquitylation of proteins. Ubiquitin is activated 
by E1 in an ATP dependent process and transferred to E2. 
E3 ligases bind to both E2 and the substrate and transfer the 
ubiquitin from E2 to the substrate. Due to the existence of 
many different E3 ligases, they can bind substrates 
specifically and they are the main specificity factor of the 
ubiquitylation process. Substrates can be mono or 
polyubiquitylated. Abbreviations: RING, Really interesting 
new gene; HECT, homologous to E6AP C-terminus; RBR, 
Ring-between-Ring. Figure adapted from Hatakeyama 







The proteasome is an ATP-dependent protease complex, which consists of two subunits. 
The 20S catalytic core subunit forms a barrel shape structure with two 19S subunits attached 
on either end (Figure 2) (Pickart and Cohen, 2004). The 20S subunit is composed of four 
stacked rings. The outer rings are composed of seven α subunits surrounding a narrow channel 
through which polypeptides can enter. These α subunits act as gates. The two inner rings are 
composed of β subunits, which make up the catalytic chamber (Smith et al., 2007). The proteins 
targeted for proteolysis by attachment of polypeptide chains are rapidly degraded by the 
proteasome to small peptides, which can be reused by the cell. The ubiquitin is either released 
and recycled (Ciechanover, 1994; Hershko et al., 1980), or degraded along with the substrate 




Figure 2: The ubiquitin proteasome pathway. 
Proteins are conjugated to ubiquitin and rapidly 
degraded by the 26S proteasome which is an ATP-
dependent complex containing the 20S core and 
two 19S regulatory subunits. Figure from Almond 






Autophagy is a lysosomal degradation pathway used to maintain internal homeostasis and avoid 
proteotoxic stress by identifying and recycling unwanted or dysfunctional cellular components. 
The word autophagy is derived from Greek and translates to “self-eating”.   
Originally autophagy was characterized by De Duve (1963) who used electron 
microscopy to study autophagy at the fusion step with the lysosome. Pfeifer and Strauss (1981) 
discovered that autophagy is regulated by nutrient conditions and Gordon and Seglen (1988) 
identified the phagophore as a sequestering organelle. Takeshige et al. (1992) found that 
autophagy in yeast is induced in nutrient-deficient conditions, and Harding et al. (1995) 
reported the Cytoplasm-to-vacuole transport (CVT) pathway in yeast that was morphologically 




were unable to accumulate autophagic bodies under nitrogen starvation (Tsukada and Ohsumi, 
1993). They named the first mutant for an autophagy gene they isolated apg1. The Thumm and 
Klionsky laboratories conducted genetic screenings in yeast for autophagy mutants (aut 
mutants) and CVT mutants (Harding et al., 1995; Thumm et al., 1994). A nomenclature for 
autophagy mutants was established, known as AuTophaGy (ATG) mutants, and several 
autophagy mutants were revealed in further genetic screening. 16 conserved core Atg proteins 
involved in autophagy in yeast have been identified (Atg1-Atg14, Atg16 and Atg18). So far a 
total of 41 putative Atg proteins have been identified in yeast (Yao et al., 2015). The studies in 
yeast led to a search for conserved genes in eukaryotes and their role in the mammalian 
autophagy system.  The mammalian homologues of the conserved yeast Atg proteins have been 
characterized in mammals (Ohsumi, 2014).  
Figure 3: Overview of the main autophagic pathways in eukaryote cells. A. Macroautophagy. B. Chaperone-
mediated autophagy (CMA) is translocation of proteins with a KFERQ motif into the lysosome through pores 
formed by LAMP2A. C. Microautophagy is the direct uptake of cytoplasmic material into the lysosome. D. 
Endosomal microautophagy is uptake of proteins with a KFERQ signal in the late endosome before being 
addressed to the lysosome. Figure from Jacomin et al. (2018). 
There are three major autophagic pathways and they are distinguished by how the cargo 
enters the lysosome (Figure 3) (Jokl and Blanco, 2016). In chaperone- mediated autophagy 
(CMA), proteins with a KFERQ motif are recognized and bound by the chaperone heat shock-
cognate protein of 70KDa (Hsc70). The substrate is targeted to the lysosome where it interacts 
with the lysosomal-associated membrane-2 protein (LAMP2A) receptor on the lysosomal 




has to be in an unfolded state, and this is most likely mediated by Hsc70 and co-chaperones 
(Cuervo and Wong, 2014; Salvador et al., 2000).   
Microautophagy was firstly described by De Duve and Wattiaux (1966). It involves 
direct uptake of cytoplasmic components into the lysosomes or endosomes (Ahlberg et al., 
1982; Li et al., 2012; Mortimore et al., 1988). There are at least three morphologically distinct 
types of microautophagy, two of which takes place at the lysosomes/vacuoles and one at the 
late endosomes (Oku and Sakai, 2018). Endosomal microautophagy is the best characterized 
type of microautophagy, and is the uptake of cytosolic proteins to late endosomes. The process 
is mediated by Hsc70, and the proteins destined for degradation have a KFERQ motif similar 
to CMA, but unlike CMA substrate unfolding and LAMP2A is not needed (Sahu et al., 2011). 
The endosomal sorting complex required for transport (ESCRT) is an assembly of protein 
subcomplexes (ESCRT I-III) and it orchestrates inward budding of the endosomal membrane 
to form vesicles that are necessary for endosomal microautophagy (Lefebvre et al., 2018). 
Mitochondria can be degraded by endosomal microautophagy through Parkin- dependent 
sequestration in Rab5- positive early endosomes in an ESCRT- dependent process 
(Hammerling et al., 2017). Upon acute amino acid starvation, a number of substrates are rapidly 
degraded by endosomal microautophagy. This degradation is mediated by ESCRT III- 
dependent delivery of proteins and mitochondria to late endosomes (Mejlvang et al., 2018).  
Macroautophagy, hereafter called autophagy, involves sequestering of cytoplasmic 
materials into double membrane vesicles termed autophagosomes. Autophagosomes fuse either 
directly with lysosomes to form autolysosomes or with late endosomes to form amphisomes. 
The amphisomes then fuses with lysosomes and forms autolysosomes (Figure 4) (Berg et al., 
1998; Nakamura and Yoshimori, 2017). The vesicular constituents are degraded in the 





Figure 4: Overview of macroautophagy. 
The autophagosomes can fuse either 
directly with the lysosomes to form 
autolysosomes or first with late endosomes 
to form amphisomes. The amphisomes then 
fuses with lysosomes to form 
autolysosomes, and the sequestered 
contents are degraded. Figure from 
Nakamura and Yoshimori (2017) with 




Early steps of autophagy 
The Unc-51-like kinase 1 (ULK1) complex comprised of ULK1 or ULK2, Focal adhesion 
kinase family-interacting protein of 200kDa (FIP200), ATG13 and ATG101 controls the 
initiation of autophagy in mammals (Ganley et al., 2009; Hosokawa et al., 2009b; Mercer et al., 
2009). ATG13 interacts directly with ATG101, FIP200 and ULK1 and mediates the interaction 
between FIP200 and ULK1 (Hosokawa et al., 2009b; Jung et al., 2009). Mammalian target of 
rapamycin (mTOR) regulate the initiation of autophagy by phosphorylating ATG13 and ULK1, 
and thereby inhibiting ULK1 kinase activity (Figure 5) (Hosokawa et al., 2009a; Jung et al., 
2009). In nutrient rich conditions mTOR is active and inhibit autophagy by binding to ULK1 
and phosphorylating ULK1 at Ser637 and Ser757 (Kim et al., 2011; Torii et al., 2016), and 
ATG13 at Ser258 (Ganley et al., 2009; Hosokawa et al., 2009a; Puente et al., 2016). Under 
starved conditions ULK1 and ATG13 is dephosphorylated and the kinase activity of ULK1 is 
activated. Furthermore, AMP-activated protein kinase (AMPK) promote autophagy under 
glucose starvation and activates ULK1 by phosphorylating ULK1 at Ser317 and Ser77 (Kim et 
al., 2011). Activated ULK1 phosphorylates ATG13 at Ser318 (Joo et al., 2011b) and FIP200 at 
Ser943, Ser986 and Ser1323 (Egan et al., 2015), and also undergoes autophosphorylation at 
Thr180, Ser1042 and Thr1046 (Bach et al., 2011; Liu et al., 2016a). These phosphorylations 
lead to their dislocation (Joo et al., 2011b; Jung et al., 2009). The mTOR binding partner raptor 
is a direct substrate of AMPK, and raptor phosphorylation is required for suppression of mTOR 
activity in response to stress (Gwinn et al., 2008). It is worth noting that mTOR and AMPK 
regulate autophagy in response to nutrient conditions. Under other conditions, such as ER stress 




nutritional signals, autophagy can be initiated through signaling by a different set of kinases, 
such as calcium/calmodulin-dependent protein kinase 1 (CAMK1) and mitogen-activated 
protein kinase 1 (MAPK1)-cyclin E-BECN1 (Corona Velazquez and Jackson, 2018; Pfisterer 
et al., 2011; Ugland et al., 2011). 
 
Figure 5: Regulation of autophagy induction 
by the TOR and AMPK complexes. Under fed 
conditions mTOR phosphorylates ULK1/2 
and ATG13, thereby inhibiting the kinase 
complex. During starved conditions, mTOR 
dependent phosphorylation sites in ULK1 are 
dephosphorylated, and ULK1 
autophosphorylates and phosphorylates 
ATG13 and FIP200. Furthermore, ULK1 is 
phosphorylated by AMPK and thereby 
activated. In addition, AMPK inhibit mTOR 
through phosphorylation of raptor, thereby 
inducing autophagy. Abbreviations: 
mTORC1, mammalian target of rapamycin complex 1; ATG, autophagy related; AMPK, AMP- activated protein 
kinase; ULK1/2, Unc-51-like kinase 1/2; FIP200, Focal adhesion kinase family interaction protein of 200 kDa. 
Figure is adapted from Alers et al. (2012), originally from Chang and Neufeld (2010), with permission from John 
Wiley and sons.  
Another complex crucial for autophagy is the phosphatidylinositol 3-kinase (PI3K) 
complex (Kametaka et al., 1998; Seglen and Gordon, 1982). Three types of PI3K have been 
identified in mammals, Class-I, -II and –III, and they are categorized based on their lipid 
substrate specificity.  
After initiation of autophagy, the ULK1 complex translocates to omegasomes. 
Omegasomes are membrane platforms connected to the endoplasmic reticulum (ER) (Axe et 
al., 2008). The ULK1 complex arrives at the autophagy initiation sites and recruits the class III 
PI3K complex. The complex consists of vacular protein sorting 34 (VPS34), VPS15/p150, 
Beclin1 and ATG14L. In mammals, there are at least two distinct class III PI3K complexes, the 
ATG14 complex and the UV radiation resistance associated (UVRAG) complex, each 
containing specific regulatory subunits that define membrane trafficking pathways (Itakura et 
al., 2008; Kihara et al., 2001). The ATG14 complex is involved in initiation of autophagy while 
the UVRAG complex is involved in later stages of the autophagic process. The PI3K class III 




membranes which stabilizes ULK1 at the omegasome and recruitment of PI3P binding proteins 
to the forming autophagosome (Karanasios et al., 2013). Among the recruited proteins are 
double FYVE-domain containing protein 1 (DFCP1) and WD-repeat protein interacting with 
phosphoinositides (WIPI) (Axe et al., 2008; Proikas-Cezanne et al., 2015). There are four WIPI 
proteins (WIPI1-4) and WIPI2b interacts directly with ATG16L and recruits the light chain 3 
(LC3) lipidation machinery, and thereby enable the formation of the autophagosome (Dooley 
et al., 2014).  
The phagophore in mammalian cells are tightly connected to ER, but contacts between 
phagophore and Golgi, endosomes, mitochondria and lysosomes have also been observed 
(Biazik et al., 2015; Yla-Anttila et al., 2009). After nucleation, the phagophore keeps growing. 









The elongation is achieved by two conjugation systems, the ATG12-ATG5-ATG16 and 
ATG8/LC3 (Figure 6). In the ATG12-ATG5-ATG16 system ATG12 is activated by E1-like 
ATG7 and transferred to E2-like ATG10 for conjugation to ATG5 (Kim et al., 1999; Shintani 
et al., 1999).  ATG16L homodimerizes and interacts with ATG5 in the ATG12-ATG5 complex 
(Kuma et al., 2002). The ATG8 family proteins are cleaved at the C-terminal by ATG4, leading 
to exposure of a glycine residue (Kirisako et al., 2000). ATG7 activates the processed ATG8 
and transfers it to the E2-like ATG3 (Ichimura et al., 2000). ATG12-ATG5-ATG16L acts as an 
E3 ligase and conjugates transfer of ATG8 from ATG3 to phosphatidylethanolamine (PE) 
(Hanada et al., 2007). PE-ATG8 associates with the inner and outer side of the growing 
Figure 6: The two conjugation systems, ATG12-
ATG5-ATG16L and ATG8/LC3. ATG12-ATG5-
ATG16L acts as an E3 ligase and transfers ATG8 
from ATG3 to PE. Figure from Dupont and 





phagophore. The ATG8-PE on the outside is released to cytoplasm by ATG4 cleavage (Kirisako 
et al., 2000).  
ATG9 is a transmembrane protein that, in yeast, traffics between pre-autophagosomal 
structures and other punctate structures in the cytoplasm (Reggiori et al., 2004). The 
mammalian ATG9 is similar, but resides in both trans-Golgi network and late endosomes. 
ATG9 shuttles around the phagophore and delivers necessary content for elongation (Orsi et 
al., 2012; Young et al., 2006). ATG9 is able to traffic to omegasomes independent of WIPI2 
and ULK1, but its retrieval is dependent on WIPI2, while ULK1 seems to regulate the 
distribution of ATG9 in areas where new omegasomes can form (Orsi et al., 2012). A recent 
study found that binding of a positive regulator of autophagy, sorting nexin 18 (SNX18), to 
Dynamin-2 is important for regulating ATG9A trafficking from recycling endosomes and for 
formation of ATG16L1 and WIPI2- positive autophagosome precursor membranes (Soreng et 
al., 2018).  
 
Late steps of autophagy 
When the autophagosome is a closed, double membrane structure it, is considered complete. 
The closure process is not yet fully understood. The ESCRT III complex is recruited to 
autophagosomes at a late step in autophagosome formation, and the ESCRT machinery 
mediates phagophore closure (Zhen et al., 2019).  Furthermore, the ATG8 conjugation system 
is believed to be essential for the closure of autophagosomes and degradation of the inner 
autophagosomal membrane (Sou et al., 2008; Tsuboyama et al., 2016). However, another study 
using ATG8 KO cells did not see any effect on autophagosome closure, but on the 
autophagosome fusion with lysosome (Nguyen et al., 2016).  
The complete autophagosome is transported to late endosome or lysosome. The 
complete autophagosome then fuse with the lysosome in a process involving Rab GTPases, 
soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNARES) and 
tethering complexes. Rab7 has a role in the maturation of late autophagic vesicles (Gutierrez et 
al., 2004; Jager et al., 2004). Rab7 also has a role in recruiting the homotypic fusion and protein 
sorting (HOPS) complex, SNAREs and the tethering factor Ectopic P granules protein 5 (EPG5) 
at the autophagosome-lysosome fusion site (Wang et al., 2016; Wijdeven et al., 2016). EPG5 
interacts with ATG8s and likely promotes the autophagosome-lysosome fusion process (Wang 





ATG8 and LIR 
Among the ATG family proteins is the ubiquitin-like ATG8 family. Mammals have six ATG8 
homologues: The microtubule-associated proteins 1A/1B LC3 (MAP1LC3) family 
(MAP1LC3A, MAP1LC3B and MAP1LC3C) and the γ-aminobutyric acid receptor-associated 
protein (GABARAP) family (GABARAP, GABARAPL1, GABARAPL2). They share 
sequence and structure similarity. They have a conserved C-terminal core consisting of four β-
strands (β1, β2, β3, β4) and two α-helices (α3, α4) and on the N-terminal end they have two α-
helices (α1, α2) (Figure 7) (Noda et al., 2009; Paz et al., 2000; Sugawara et al., 2004). 
 
Figure 7: Structural comparison of ubiquitin and LC3. α-helices are shown in purple, β-strands in yellow, β-turns 
in cyan and unstructured loops in white. Figure is adapted from Geng and Klionsky (2008), originally from  
Sugawara et al. (2004) and Vijay-Kumar et al. (1987) with permission from Elsevier (Ubiquitin) and John Wiley 
and sons (LC3). 
 The ATG8 homologues have β-strands which makes two hydrophopic pockets 
(HP1 and HP2). HP1 is deep and formed between α2 and β2 and accommodates hydrophopic 
aromatic residues while HP2 is formed between α3 and β2 and accommodates hydrophobic 
aliphatic residues. HP1 and HP2 binds to a short linear motif known as LC3 interacting region 
(LIR), and HP1 and HP2 makes up the LIR docking site (LDS) on the ATG8. The LIR 
consensus sequences contain [W/F/Y]XX[L/I/V] where X denotes any amino acid. W and F at 
the aromatic position binding to HP1 is most common, but a few have Y at this position. The 
hydrophobic residue at position four binds to HP2 (Birgisdottir et al., 2013; Noda et al., 2008; 
Pankiv et al., 2007). Acidic residues (E, D, S or T) often flank the core motif and they are 
involved in electrostatic interactions with the N-terminal helices of the ATG8 (Birgisdottir et 
al., 2013). The first LIR was identified in the autophagy receptor p62/Sequestosome-1 
(SQSTM1), hereafter called p62 (Bjorkoy et al., 2005; Pankiv et al., 2007). Autophagy 




ATG14 and VPS34 in the PI3K class III complex all have LIR motifs with a clear preference 
for GABARAP and GABARAPL1 (Birgisdottir et al., 2019).  
 Recently, Marshall et al. (2019) found a new class of ATG8 interactors in Arabidopsis 
thaliana. They found that ubiquitin-interacting motif (UIM)-like sequences could bind to an 
alternative site on the ATG8s called UIM docking site (UDS) (Marshall et al., 2019).  
 
Selective autophagy  
While UPS is a highly specific and selective route for protein degradation, autophagy was 
initially believed to be a non-selective, bulk degradation process mainly induced to replenish 
energy stores upon starvation (Cohen-Kaplan et al., 2016). However, during the last decade 
evidence have accumulated showing that autophagy can be highly selective. Specific receptors 
have been found to recognize and deliver proteins and organelles exclusively to 
autophagosomes, showing that autophagy also can be a selective process (Kirkin, 2019; Rogov 
et al., 2014).  
When cells are stressed by ischemia, hypoxia, starvation or infection, selective 
autophagy is induced and specifically targets excess or toxic structures, thereby allowing the 
cell to adapt to the unfavorable conditions (Johansen and Lamark, 2011). Selective autophagy 
can be further divided based on their particular type of cargo. 
For each type of cargo there are selective autophagy receptors (SAR) that bind the cargo 
and dock on the forming phagophore to enable the degradation of the cargo (Kirkin and Rogov, 
2019). The first autophagic receptor to be recognized was p62, which interacts both with LC3B 
and cargo, and thereby deliver specific cargo to the autophagosomes. p62 itself is degraded with 
the cargo in the process (Bjorkoy et al., 2005; Pankiv et al., 2007).  
Several other autophagy receptors have later been identified, and a group of proteins 
with similarity to p62 have been named sequestosome-1-like receptors (SLRs) (Figure 8). This 
group includes p62, Neighbor of BRCA1 gene1 (NBR1), Nuclear Dot protein-52 (NDP52), 
Optineurin (OPTN) and human T-cell leukemia virus type 1 binding protein (TAX1BP1). The 
SLRs can be considered as functional homologues. All of them recognize ubiquitylated 
substrates, interact directly with ATG8 homologues via LIR-LDS interactions, direct the 
substrate to lysosomal degradation and they get degraded themselves with the substrate (Kirkin 
et al., 2009; Thurston et al., 2009; Wild et al., 2011). Furthermore, NDP52 and p62 can 
oligomerize independently or as hetero-oligomers in a three-dimensional helical assembly 




al., 2009). Autophagy-linked FYVE (ALFY) is another SLR which interacts with LC3C and 
the GABARAPs through a LIR domain (Lystad et al., 2014). It interacts with p62, binds to PI3P 
and contributes to clearance of aggregated proteins, midbody remnants and viral particles 
(Clausen et al., 2010; Filimonenko et al., 2010; Isakson et al., 2013; Mandell et al., 2014a; 
Simonsen et al., 2004). 
Another group of autophagy receptors is the membrane-associated autophagy receptors. 
They include the mitophagy receptors BCL2 and adenovirus E1B 19 kDa-interacting protein 3 
(BNIP3), BNIP3-like protein (BNIP3L, also known as NIX), FK506 binding protein 8 (FKBP8) 
and FUN14 domain-containing protein 1 (FUNDC1) (Bhujabal et al., 2017; Hanna et al., 2012; 
Liu et al., 2012; Novak et al., 2010). Other membrane-associated autophagy receptors include 
the ER-phagy receptors cell-cycle progression gene 1 (CCPG1) and Reticulon-3 (RTN3) 
(Grumati et al., 2018; Grumati et al., 2017; Smith et al., 2018), the glycophagy receptor starch-
binding domain containing protein 1 (STBD1) (Jiang et al., 2011) and Atg39 is a membrane-
associated receptor for yeast nucleophagy (Mochida et al., 2015; Papandreou and Tavernarakis, 
2019). Other autophagy receptors include the ferritinophagy receptor nuclear receptor 
coactivator 4 (NCOA4) (Mancias et al., 2014), and Tripartite motif (TRIM) proteins, which 
recognize many different targets, such as virus and aggregates, and assembles effectors and 






Figure 8: Domain structure of SLRs and other SARs. Indicated motifs and domains: PB1, Phox and Bem1 domain; 
ZZ, ZZ-type zinc finger domain; CC, coiled coil domain; NLS, nuclear localization signal; NES, nuclear export 
signal; LIR, LC3-interacting region; KIR, KEAP1 interacting region; UBA, ubiquitin-associated domain; FW, 
four tryptophan domain; SKICH, SKIP carboxyl homology domain; ZF, zinc finger domain; UBAN, ubiquitin 
binding in ABIN and NEMO domain; RING, RING finger domain; BB, B-box domain; SPRY, SPRY domain; 
CBM20, family 20 carbohydrate-binding module domain; TM, transmembrane domain. The green boxes indicate 
ubiquitin binding domains. Figure is from Johansen and Lamark (2019), with permission from Elsevier. The 




The domain architecture of p62 show an N-terminal self-interacting PB1 domain, followed by 
ZZ-type zinc finger domain, two nuclear localization signals (NLS), a nuclear export signal 
(NES), a LIR motif, a KEAP1 interacting region (KIR) and a C-terminal ubiquitin associated 
(UBA) domain (Figure 8) (Pankiv et al., 2007; Pankiv et al., 2010). In addition to self-
interacting, the PB1 domain interacts with atypical protein kinase Cs, mitogen activated protein 
kinase kinase 5 (MEK5) and NBR1 (Lamark et al., 2003; Sanchez et al., 1998; Wilson et al., 




linked polyubiquitin chains. Furthermore, p62 docks directly unto Kelch-like ECH-associated 
protein 1 (KEAP1) via the KIR motif (Jain et al., 2010).  
p62 undergoes polymerization with the PB1 domain, and form long polymeric chains. 
These polymeric chains are mixed with ubiquitin chains and leads to phase separation and 
structures referred to as droplets (Sun et al., 2018; Zaffagnini et al., 2018). p62 then connects 
the cargo to the autophagosome through a LIR- mediated interaction with the ATG8s (Lamark 
et al., 2003). Thus, p62 select specific cargo for degradation by the lysosome. p62 itself is also 
degraded by the lysosome in the process (Bjorkoy et al., 2005).  
 In autophagy deficient cells p62 accumulates in aggregates. The accumulation of p62 
aggregates have been linked to diseases affecting both the brain and the liver. These diseases 
include Lewy bodies in dementia, Alzheimer’s disease, and huntingtin aggregates in the brain 
(Komatsu et al., 2007; Kuusisto et al., 2001; Nagaoka et al., 2004; Zatloukal et al., 2002), and 
Mallory bodies, hyaline bodies and α1 antitrypsin aggregates in the liver (Zatloukal et al., 
2002). The p62 aggregates are positive for ubiquitin and they form in response to stress, such 
as amino acid starvation, oxidative stress, accumulation of defective ribosomal products, or 
inhibition of autophagy (Komatsu et al., 2007; Pankiv et al., 2007). 
 NF-E2-related factor 2 (NRF2) is a transcription factor that regulates the transcription 
of antioxidant genes. During non-stress conditions KEAP1 forms a complex with Cullin3 
(Cul3), the KEAP1-Cul3 complex, which polyubiquitylates NRF2 and destines it for 
degradation (Cullinan et al., 2004; Kobayashi et al., 2004). During oxidative stress, KEAP1 is 
destabilized and interacts with p62 through the KIR domain on p62 and the NRF2 binding site 
on KEAP1, sequestering it in aggregates (Jain et al., 2010; Komatsu et al., 2010). This 
interaction titrates KEAP1 away from NRF2, stabilizing NRF2. Furthermore, p62 induction is 
mediated by NRF2 and p62-KEAP1 interaction is required for p62 to stabilize NRF2 (Jain et 
al., 2010).  The LIR and KIR domains are localized close to each other and cannot be utilized 
simultaneously.  
 Post-translation modifications of p62 have been shown to regulate its function. 
Phosphorylation of the UBA domain at Ser409 and Ser405 by ULK1 and Ser403 by TANK-
binding kinase 1 (TBK1) and Casein kinase 2 (CK2) increase the binding affinity of p62 to 
ubiquitin (Lim et al., 2015; Matsumoto et al., 2011; Pilli et al., 2012). Furthermore, 
ubiquitylation of p62 can modulate the p62 function. An E2 interacting region (EIR) was 
mapped to residues 294-320, which precedes the LIR domain. Two E2 conjugating enzymes, 
UBE2D2 and UBE2D3, interacts directly with p62 through the EIR domain (Peng et al., 2017). 




sequestration of proteins (Pan et al., 2016). Ring finger protein 26 (RNF26) ubiquitylates p62 
in the UBA domain, thereby enhancing interaction between p62 and other ubiquitin adaptors 
such as Toll-interacting protein (TOLLIP) and facilitating vesicular cargo sorting (Jongsma et 
al., 2016). RNF166 ubiquitylates p62 at Lys91 and Lys189, facilitating p62’s role in xenophagic 
degradation of intracellular bacteria (Heath et al., 2016). The KEAP1-Cul3 complex 
ubiquitylates p62 in the UBA domain at Lys420, and this ubiquitylation may regulate p62 
function (Lee et al., 2017).  
 
NDP52 
NDP52 has a SKIP carboxyl homology (SKICH) domain, a coiled-coil region, a C-LIR motif 
and a C-terminal Ubiquitin binding zinc finger (UBZ) domain (Figure 8). NDP52 interacts with 
nucleasome assembly protein 1 (NAP1) in unique heterotetramers through its SKICH domain 
and recruit TBK1 (Fu et al., 2018). TBK1 regulate the autophagic functions of NDP52 by 
phosphorylation, including phosphorylation of positions in the SKICH domain (Heo et al., 
2015). The UBZ domain recognizes ubiquitylated proteins (Xie et al., 2015a).  
 NDP52 recognizes and targets ubiquitin coated Salmonella for degradation (Thurston et 
al., 2009). Furthermore, NDP52 mediates selective autophagic degradation of retrotransposon 
RNA, DICER and protein argonaute-2 (Ago2) in the miRNA pathway, mitochondrial antiviral 
signaling protein (MAVS) in immune signaling, the signaling adaptor protein TIR domain-
containing adaptor molecule 1 (TRIF) and Myeloid differentiation primary response protein 
MyD88 (MyD88)  (Gibbings et al., 2012; Guo et al., 2014; Inomata et al., 2012; Jin et al., 2017). 
NDP52 form a trimeric complex with FIP200 and NAP1 and promote progression of anti-
bacterial autophagy (xenophagy) (Ravenhill et al., 2019). 
 NDP52 has a Galectin-8 (Gal8) interacting region between position 371 and 381, the 
area between the coiled coil and UBZ domains (Thurston et al., 2012). The sequence form a 
hook-like structure that strategically places side chains for hydrophobic interactions with Gal8 
(Li et al., 2013). Two tyrosine residues in NDP52, Tyr376 and Tyr380, specifically interacts 
with two tyrosine residues in Gal8, Tyr266 and Tyr272 (Kim et al., 2013).  
NDP52 has also been reported to play a role in mitophagy. NDP52 is recruited to the 
mitochondria by the internal mitochondrial protein PTEN-induced kinase 1 (PINK1). 
Furthermore, NDP52 and OPTN recruit the autophagy initiation machinery and the ATG8s for 
degradation of mitochondria (Lazarou et al., 2015). NDP52 interacts with ULK1 through 




mitophagy (Vargas et al., 2019). The capability of NDP52 to induce mitophagy is dependent 
on its interaction with the ULK1 complex.  




TRIM family proteins have many different roles in the cells, including intracellular signaling, 
transcription, autophagy, innate immunity, cell cycle progression, DNA repair and 
carcinogenesis. There are 77 different human TRIM proteins known (Figure 9) (Hatakeyama, 
2017). The TRIM family proteins are characterized by a RING domain, one or two B box 
domains, a coiled coil domain and a variable C-terminal domain. The arrangement is conserved 
through evolution, supporting that it has a functional relevance (Reymond et al., 2001). The 
RING domain is a specialized zinc finger and constitutes E3 ligase activity. A number of TRIM 
proteins have also been shown to self-ubiquitylate through the RING domain (Duan et al., 2008; 
Huang et al., 2013; Yamauchi et al., 2008). There are some TRIM proteins that lack the RING 
domain but they are evolutionary closely related, and TRIM16 has been shown to have E3 
ubiquitin ligase activity through its B-box domain (Bell et al., 2012; Hatakeyama, 2017). B-box 
domains are zinc-binding motifs and their function is not fully understood, but they are involved 
in homo-oligomerization of TRIM5α and in autoinhibition of TRIM21 (Diaz-Griffero et al., 
2009; Dickson et al., 2018). Many TRIM proteins homodimerize through the coiled coil 
domain, and it occurs in an antiparallel fashion positioning the N-terminal RING domains at 
opposite ends of the dimer (Reymond et al., 2001; Sanchez et al., 2014).  
 The TRIM proteins are categorized into 11 different subgroups based on their C-
terminal domain, which can contain any of 10 different motifs either alone or in combination 
(Figure 9) (Ozato et al., 2008). The C-terminal domain facilitate substrate recruitment, but can 
also have additional roles. The C-terminal domain of class VI is a plant homeodomain (PHD) 
which has small ubiquitin-like modifier (SUMO) E3 ligase activity (Ivanov et al., 2007). 
Furthermore, TRIM28, which is a class VI TRIM protein, does not harbor E3 ligase activity on 
its own and is unable to self-associate (Stevens et al., 2019). 
Several TRIM proteins are shown to regulate autophagy. TRIM55/MuRF2 was the first 
TRIM protein shown to interact with p62 and it has a role in the turnover of muscle proteins 
(Lange et al., 2005; Perera et al., 2011). Mandell et al. (2014a) used a small interfering (si)RNA 




family have been shown to promote autophagy induction by interacting with ULK1 and Beclin1 
(Chauhan et al., 2016; Fusco et al., 2018; Mandell et al., 2014a). Furthermore, some TRIM 
proteins act as selective autophagy receptors by binding cargo and ATG8 family proteins to 
mediate autophagic degradation (Mandell et al., 2014a). An example is TRIM5α which 
recognize and targets HIV-1 for autophagic degradation (Mandell et al., 2014b). In contrast to 
the autophagy- promoting TRIMs, such as TRIM5α, TRIM17 protects a variety of selective 
autophagy targets from degradation. However, TRIM17 also contribute to the elimination of 
midbodies, thus, depending on the target, either positively or negatively regulate autophagy 
(Mandell et al., 2016). 
Ubiquitylation of TRIM proteins are shown to implicate their roles in the TRIMs role 
in autophagy. Imam et al. (2019) show that K63-linked ubiquitylation is required for the 
association of TRIM5α with autophagosomal membranes and p62. TRIM13 is a transmembrane 
protein localized in the ER membrane, and it is an ubiquitin dependent ER-phagy receptor (Ji 
et al., 2019).  K63-ubiquitylated TRIM13 recruits p62, and the TRIM13-p62 complex 
undergoes oligomerization. The oligomerized complexes are separated along with ER 
compartments and targeted to autophagosomes (Ji et al., 2019). TRIM32 is required for muscle 
autophagy in atrophic conditions by binding Activating molecule in BECN1-regulated 
autophagy protein 1 (AMBRA1) and ULK1, and stimulate ULK1 activity through K63-linked 





Figure 9: The TRIM family proteins are classified from C-1 to C-XI, and an unclassified group which lacks the 
RING domain. Abbreviations: R, RING finger domain; B1, B-box domain 1; B2, B-box domain 2; CC, coiled-coil 
domain; COS, cos box; FN3, fibronectin type III repeat; PRY, PRY domain; SPRY, SPRY domain; ACID, acid-
rich region; FIL, Filamin-type IG domain; NHL, NHL domain; PHD, PHD domain; BROMO, bromodomain; 
MATH, Meprin and TRAF homology domain; ARF, ADP-ribosylation factor family domain; TM, transmembrane 




TRIM proteins are associated with several diseases, including cancer, infectious 
diseases, developmental diseases and neuropsychiatric disorders (Watanabe and Hatakeyama, 
2017). Many TRIM proteins have roles in cancers, both as tumor suppressors and as oncogenes. 
Translocation of TRIM19 is involved in acute promyelocytic leukaemia (APL) (Goddard et al., 
1991; Kakizuka et al., 1991). TRIM24 is an oncogenic transcriptional activator that promotes 
cell growth in prostate cancer cells, and as a proliferation regulator in gastric cancer and 
hepatocellular carcinoma (Fang et al., 2017b; Groner et al., 2016). TRIM28 have been reported 
to play a role in regulating DNA damage response (DDR) (White et al., 2012), cell 
differentiation (Chen et al., 2012a), immune response (Tie et al., 2018) and tumorigenesis 
(Fitzgerald et al., 2013; Hu et al., 2015). Furthermore, TRIM28 function as a tumor promoter 
in B-cell non-Hodgkin lymphoma (B-NHL) (Zhang et al., 2018b). TRIM22 and TRIM24 target 
p53 for degradation (Appikonda et al., 2016; Obad et al., 2004) while TRIM13 overexpression 
causes stabilization of p53 followed by induction of apoptosis (Joo et al., 2011a). TRIM29 
regulates the Wnt/β-catenin signaling pathway and acts as an oncogene in gastric cancer (Qiu 
et al., 2015), while TRIM8 is downregulated in glioma tissues and interacts with and negatively 
regulates Protein inhibitors of activated STAT (PIAS3) (Micale et al., 2015; Okumura et al., 
2010). 
TRIM proteins also play important roles in innate immunity. TRIM52 activates NF-κB 
signaling, and this activation is dependent on the RING domain. Furthermore, TRIM52 
expression is induced by tumor necrosis factor α (TNFα) and interleukin 1β (IL-1β) expression 
(Fan et al., 2017). TRIM38 interacts with TNFR-associated factor 6 (TRAF6) and promotes 
K48-linked polyubiquitylation and thereby proteasomal degradation of TRAF6 (Zhao et al., 
2012). TRIM39 interacts with Cactus interactor (Cactin). Cactin inhibit NF-κB and Toll-like 
receptor (TLR)-mediated transcriptions, and TRIM39 suppresses the NF-κB signal through 
stabilization of Cactin (Suzuki et al., 2016). TRIM7 may serve as a positive regulator of TLR4-
mediated signaling (Lu et al., 2019), while TRIM9 is a positive regulator of type I interferon 
(IFN) signaling and a negative regulator of NF-κB activation (Qin et al., 2016; Shi et al., 2014). 
Furthermore, TRIM proteins have roles in other diseases. Single nucleotide 
polymorphisms (SNPs) in TRIM10, TRIM15, TRIM26, TRIM39 and TRIM40 were discovered 
using a genome wide association (GWA) studies in multiple sclerosis (MS) (Baranzini et al., 
2009). TRIM3 is upregulated in schizophrenia (Martins-de-Souza et al., 2009), and a GWA 
study found a mutation in the RING domain of TRIM19 in schizophrenia patients (Xu et al., 
2011). Another GWA study found that two SNP mutations in TRIM76 are associated with 




Alzheimer’s disease (Arra et al., 2007). Three different TRIM proteins are shown to associate 
with attention deficit hyperactivity disorder (ADHD): a rare copy number variations in 
TRIM32, a SNP in TRIM31 and a SNP in TRIM33 (Lionel et al., 2011; Rizzi et al., 2011; Xia 




TRIM32 is a 653 amino acids long protein and it has six NHL (NCL-1/HT2A/LIN-41, which 
are the proteins where the domain initially was described) repeats as its C-terminal domain and 
is therefore part of the NHL-family (Figure 9, 10). The NHL domain is involved in protein 
dimerization and substrate recognition (Koliopoulos et al., 2016). Furthermore, Loedige et al. 
(2014) found that all TRIM-NHL proteins have a positively charged top surface, which may 
suggest that RNA binding is a conserved feature of the NHL-family. However, the RNA targets 
may vary between the NHL domains and therefore the TRIM proteins in this family may have 
different roles (Kumari et al., 2018).  
 
Figure 10: Domains of TRIM32 and the localization of the pathogenic mutations. Abbreviations: BBS11, Bardet 
Biedl syndrome 11; LGMD2H, Limb girdle muscular dystrophy 2H; RING, Really interesting new gene; NHL, 
NCL-1/HT2A/LIN-41. Figure from Shieh et al. (2011) with permission from Elsevier. 
TRIM32 is expressed throughout the body but with highest expression in the heart and 
brain (Frosk et al., 2002). The B-box cooperate with the RING domain to specify TRIM32 
subcellular localization (Lazzari et al., 2019). Furthermore, studies suggests that the B-box is 
coordinating TRIM interactions, both self-interaction and protein-protein interactions (Li et al., 
2011; Tao et al., 2008; Wallenhammar et al., 2017). The B-box contains a zinc-finger motif and 
it has therefore been suspected that it confer some E3 ligase activity (Bell et al., 2012). 
However, a recent study showed that this was not the case for TRIM32 (Lazzari et al., 2019).  
 During cell division, TRIM32 localizes at the spindle poles through a recruitment 
mediated by Cdk1/cyclin B phosphorylation (Izumi and Kaneko, 2014). At the spindle poles 
TRIM32 interacts with and poly-ubiquitylates MYCN and destines it for degradation, thereby 




myofibrils and ubiquitylates actin, and likely has a role in myofibrillar protein turnover during 
muscle adaption (Kudryashova et al., 2005). TRIM32 is important for neuronal differentiation 
of neural progenitor cells and ubiquitylates cMyc, targeting it for degradation (Hillje et al., 
2011). In mice, the myogenic differentiation is disrupted in adult muscle stem cells in absence 
of TRIM32 (Nicklas et al., 2012). Furthermore, TRIM32 interacts with the deubiquitylating 
enzyme herpesvirus- associated ubiquitin specific protease (USP7) and USP7 deubiquitylates 
and stabilizes c-Myc (Nicklas et al., 2019). TRIM32 interacts with Argonaute1 (Ago1), but 
Ago1 is not ubiquitylated by TRIM32. However, TRIM32 activates miRNA Let-7a through the 
Ago1 interaction (Schwamborn et al., 2009). Cyclic GMP-AMP synthase (cGAS) detect virus 
infection and produces a second messenger to activate stimulator of IFN genes (STING). 
TRIM32 has a role in the cGAS-STING pathway by ubiquitylating NEMO, which subsequently 
activates IKKβ. IKKβ is required for TBK1 and NF-κB activation, which are required for the 
cGAS-STING activation (Fang et al., 2017a). Furthermore, TRIM32 ubiquitylates STING itself 
at multiple residues, which promotes the interaction of STING with TBK1 (Zhang et al., 2012). 
Other targets of TRIM32 includes dysbindin, p53, Oct4, PIAS3 and N-myc down-regulated 
protein 2 (NDRG2) (Bahnassawy et al., 2015; Liu et al., 2014; Locke et al., 2009; Mokhonova 
et al., 2015; Qu et al., 2007). 
TRIM32 has a role in autophagy by regulating ULK1 activity in muscles under atrophy 
conditions (Di Rienzo et al., 2019). TRIM32 is transported to ULK1 by AMBRA, an autophagy 
cofactor, to stimulate its kinase activity through unanchored K63-linked polyubiquitin chains. 
Notably, in a recent study Di Rienzo et al. (2019) found that mutations in TRIM32 responsible 
for the LGMD2H disrupts its ability to bind ULK1 and induce autophagy in muscle cells. 
TRIM32 undergoes auto-ubiquitylation in the presence of E2 enzymes belonging to the 
subfamily of D and E enzymes. Furthermore, TRIM32 produce K63- polyubiquitin chains with 
the E2 UBE2N (Kudryashova et al., 2005; Lazzari et al., 2019; Napolitano et al., 2011). 
TRIM32 is associated with limb girdle muscular dystrophy 2H (LGMD2H) through 
seven mutations in the NHL domain (D487N, R394H, V591M, D588del, T520TfsX13, 
L535SfsX21 and I590LfsX38) (Frosk et al., 2002; Servian-Morilla et al., 2019), and a 
completely unrelated disease, a multisystemic disorder called Bardet Biedl Syndrome 11 
(BBS11) through a point mutation in the B-box domain (P130S) (Chiang et al., 2006). BBS11 
is characterized by obesity, retinal degradation, genito-urinary tract malformations, and 
cognitive impairment, but not showing muscle alterations (Chiang et al., 2006). Interestingly, 
the TRIM32 LGMD2H mutants D487N and R394H lost their E3 ligase activity and were unable 




TRIM32 KO model and found that muscular dystrophy due to TRIM32 mutations involves both 
neurogenic and myogenic characteristics. Furthermore, studies on the TRIM32 KO mice have 
shown that TRIM32 plays a key role in muscle regrowth after atrophy, but it is not necessary 
to trigger muscle atrophy (Kudryashova et al., 2012). The same group generated TRIM32 knock 
in (KI) mice and found that the LGMD2H mutation destabilizes the protein, leading to its 
degradation, and results in the same phenotype as the TRIM32 null mice (Kudryashova et al., 
2011). The pathological mechanism of LGMD2H is unknown, however there are theories that 
the muscle dystrophy is due to the loss of E3 ligase activity or the loss of interaction properties 
of the mutated TRIM32 (Frosk et al., 2002; Locke et al., 2009; Saccone et al., 2008). 
TRIM32 has important roles in other diseases than LGMD2H and BBS11, including 
cancers. TRIM32 is upregulated in breast tumors and promote cell growth through activation 
of the NFB signaling pathway (Zhao et al., 2018). It activates RARα-mediated transcription 
and thereby function as a tumor suppressor (Sato et al., 2011). TRIM32 also acts as an oncogene 
because it degrades tumor suppressor Abl interactor 2 (ABI2) and thereby promotes cell 
proliferation, transformation and metastasis in squamous cell carcinoma, papilloma and head 
and neck carcinoma (Horn et al., 2004; Kano et al., 2008). TRIM32 is upregulated in 
hepatocellular carcinoma (HCC) cell tissues and cell lines. Furthermore, the overexpression 
was coupled with inhibition of apoptosis (Cui et al., 2016). A recent study found that TRIM32 
interacts with and degrades the transcription factor Gli1, and thereby negatively regulates the 
sonic hedgehog (SHH) signaling. By this regulation of SHH signaling TRIM32 acts as a tumor 
suppressor (Wang et al., 2019). TRIM32 has an important role in p53-mediated cellular stress 
responses. In response to stress, p53 induce expression of TRIM32. In turn, TRIM32 interacts 
with p53 and promotes p53 degradation. Thus, TRIM32 and p53 form an auto-regulatory 
negative feedback loop for p53 regulation in cells (Liu et al., 2014). TRIM32 also regulate 
Parkinson’s disease (PD) by positively influencing the PD associated gene alpha-synuclein 
(snca) (Pavlou et al., 2017).  
 
TRIM27 
TRIM27, also called Zinc finger protein and RET finger protein (RFP), is 513 amino acids long, 
has a PRY/SPRY domain and is a part of the largest subclass of TRIM proteins, C-IV (Figure 
9, 11). The PRY/SPRY domain confer target specificity for the E3 ligase activity (Ozato et al., 




oncogene (Takahashi et al., 1985). TRIM27 may be localized to cytoplasm, nucleus and plasma 
membrane depending on the cell type (Tezel et al., 1999). 
 
Figure 11: Domains of TRIM27. Abbreviations: RING, Really interesting new gene; LIR, LC3 interacting region; 
PRY, PRY domain; SPRY, SPRY domain; CC, coiled coil domain. 
TRIM27 has roles in cell proliferation, transcriptional repression, negative regulation of 
NF-B activation, apoptosis and innate immune response (Ma et al., 2016; Shimono et al., 
2000; Zha et al., 2006; Zheng et al., 2015). TRIM27 interacts with several transcription factors, 
including enhancer of polycomb (EPC1), Mi-2β, retinoblastoma protein (RB1) and basic helix-
loop-helix (bHLH) family members (Bloor et al., 2005; Krutzfeldt et al., 2005; Shimono et al., 
2000; Shimono et al., 2003). TRIM27 makes a complex with USP7, and the TRIM27-USP7 
complex regulate complexes involved in endosomal trafficking, immune responses, autophagy 
and apoptosis (Cai et al., 2018; Hao et al., 2015; Zaman et al., 2013). Recently it was shown 
that TRIM27 mediates signal transducer and activator of transcription 3 (STAT3) activation 
promoting colitis and colitis-associated carcinogenesis (Zhang et al., 2018a). STAT3 is 
overexpressed and constitutively active in triple-negative breast cancer cells and contributes to 
cell survival, proliferation, invasion, angiogenesis, immunosuppression and chemoresistance 
by regulatin expression of its downstream targets (Qin et al., 2019).  
TRIM27 is highly expressed in a number of cancers, including breast, endometrian, 
ovarian, lung and colon cancers (Horio et al., 2012; Iwakoshi et al., 2012; Tezel et al., 2002; 
Tezel et al., 2009; Tsukamoto et al., 2009). High expression of TRIM27 predicts poor prognosis 
in breast and endometrial cancer (Zoumpoulidou et al., 2012). TRIM27 interacts with PML 
nuclear bodies (NB) through the B-box and CC domains of TRIM27. Furthermore, TRIM27 
have a role in regulating cellular growth and differentiation in PML (Cao et al., 1998). High 
expression of TRIM27 correlates with proliferation, migration and chemosensitivity for some 
tumor cells, and TRIM27 could act as a potential prognostic indicator in some cancers. Tezel 
et al. (2009) found that TRIM27 is localized in breast carcinomas and not in benign breast 
tissue. 
TRIM27 binds and ubiquitylates nucleotide-binding oligomerization domain-containing 




TRIM27 was found to have increased expression in Crohn’s disease patients (Zurek et al., 
2012).  
 
Aim of study 
This study cover works on TRIM proteins and their roles in autophagy. At the time this study 
was initiated, certain TRIM proteins had been recognized to act as autophagy receptors. Our 
hypothesis was that within the nearly 80 different proteins of the TRIM family, additional ones 
are degraded by autophagy and act as autophagy receptors.  
 
The following aims were defined to test this hypothesis: 
1. Apply a fluorescent double-tagged- screen to identify TRIM proteins degraded by the 
lysosome 
2. Identify if these TRIM proteins have roles as autophagy regulators 





















Summary of papers 
Paper I 
TRIM32, but not its muscular dystrophy-associated mutant, positively regulates and is 
targeted to autophagic degradation by p62/SQSTM1.   
Overå, K.S., Garcia, J.G., Bhujabal, Z., Jain, A., Øvervatn, A., Larsen, K.B., Deretic, V., 
Johansen, T., Lamark, T., and Sjøttem, E. (2019).  
J. Cell Science.  PMID 31828304. 
In this paper we employed a fluorescence- based double tag screen of 22 TRIM proteins, 
representing each of the TRIM subfamilies. Interaction studies in vivo and in vitro revealed co-
localization of TRIM32 and p62 and LC3B, and direct binding between TRIM32 and p62. 
Furthermore, autophagy assays showed that lysosomal degradation of TRIM32 was dependent 
on ATG7 and the sequestosome-like receptors receptors. p62 was able to mediate degradation 
of TRIM32, while ubiquitylation assays identified p62 as a substrate of TRIM32. TRIM32 
mono-ubiquitylated p62 on lysine residues involved in regulation of p62 activity. The muscle 
dystrophy LGMD2H mutant of TRIM32 was not able to undergo autophagic degradation, and 
also failed to ubiquitylate p62. In contrast, the BBS11 mutant strongly facilitated p62 
ubiquitylation, sequestration and degradation. This indicates a dual role for TRIM32 in 
autophagy, both as a p62 cargo and as a positive regulator of p62. Importantly, the functional 
assays of the LGMD2H disease mutant point towards dysfunctional TRIM32 mediated 
regulation of p62 as a pathological mechanism in LGMD2H.  
  
Paper II 
TRIM32 – a putative regulator of NDP52 mediated selective autophagy 
Overå, K.S., Bhujabal, Z., Garcia, J.G., Sjøttem, E.  
Manuscript 
In paper II we show that TRIM32 downregulates the protein levels of all SLR proteins, without 
affecting their expression at the RNA level. Autophagic degradation of TRIM32 is dependent 
on SLRs, and we found that NDP52 are able to direct TRIM32 to degradation in the lysosome. 
TRIM32 interacts directly with and ubiquitylates NDP52. Furthermore, a mitophagy assay 
showed that mitophagy is reduced in HEK293 TRIM32 KO cells compared to normal HEK293 
cells and TRIM32 KO cells reconstituted with TRIM32. Expression of TRIM32 WT and the 




autophosphorylation, while expression of the LGMD2H mutant did not. Thus, this study 
identify TRIM32 as a potential regulator of NDP52, ULK1 and TBK1, facilitating mitophagy.  
 
Paper III 
TRIM27 is an autophagic substrate and putative regulator of LC3B 
Garcia, J.G., Overå, K.S., Knutsen, E., Bhujabal, Z., Evjen, G., Lamark, T., Johansen, T., 
Sjøttem, E. 
Manuscript 
Here we identify TRIM27 as an autophagic substrate, depending on ATG7 and the SLRs for its 
lysosomal degradation. We mapped a LIR domain in its coiled coil region with specificity 
towards LC3C and GABARAP. Establishment of TRIM27 KO cells showed that TRIM27 do 
not affect the starvation induced autophagy response. However, loss of TRIM27 affected p62 
and LC3B protein levels under nucleotide mediated stress, mimicking virus induced activation 
of the innate immune response. The HEK293 TRIM27 KO cells displayed enhanced 
proliferation rate and reduced cell migration, suggesting that TRIM27 may have a role in 
epithelial-mesenchymal transition. Both TRIM27 and LC3B were aberrantly expressed in 
various breast cancer cell lines, and their expression levels seemed to be inversely correlated. 
Thus, these cell lines are potent model systems to identify the roles of TRIM27 and autophagy 



















In this thesis, we started out by doing a screen of 22 different TRIM proteins representing each 
of the 11 TRIM family subgroups to identify candidates with a potential role in autophagy. 
Earlier publications had already recognized a number of TRIMs, including TRIM5α, TRIM13, 
TRIM16, TRIM20, TRIM21 and TRIM63, as regulators and receptors in selective autophagy 
(Chauhan et al., 2016; Kimura et al., 2017; Kimura et al., 2016; Mandell et al., 2014b). In our 
screen we further identified TRIM32, TRIM27 and TRIM45 as potential autophagic substrates. 
In paper I we investigated the role of TRIM32 in autophagy, and found it to be a substrate of 
p62. Furthermore, we found TRIM32 to be a direct interactor of p62, and to regulate p62 activity 
by ubiquitylation. This ubiquitylation was abolished in mutants of TRIM32 implicated in the 
muscular dystrophy disease LGMD2H. In paper II we studied the role of TRIM32 in association 
with the four other SLRs, and found it to interact with and ubiquitylate NDP52. NDP52 is 
involved in mitophagy and xenophagy in cooperation with the ULK1 complex and TBK1. 
Interestingly, we found mitophagy to be reduced in TRIM32 KO cells. In paper III, we identify 
TRIM27 as an autophagic substrate. However, TRIM27 does not seem to affect autophagy 
activity under normal or starved conditions. However, under infectious stress mimicked by poly 
(AT) or plasmid transfections, the p62 and LC3B response was impaired in TRIM27 KO cells. 
Furthermore, we found TRIM27 mRNA levels to be strongly upregulated in cancer tissue from 
breast cancer patients, and in various breast cancer cell lines TRIM27 was aberrantly expressed 
and its expression level seemed to be inversely correlated with LC3B expression. 
 For a more detailed discussion than provided below, please look at the discussion in 
each of the papers. 
 
TRIM32 and autophagy proteins 
LC3-I is localized in the cytosol, but it is conjugated to PE to form LC3-II, which is localized 
on the outer and inner membrane of the autophagosome (Kabeya et al., 2000). LC3 is a widely 
used autophagy marker because the number of LC3-II reflects the number of autophagosomes 
(Yoshii and Mizushima, 2017). Another marker for autophagy is p62 because it binds to LC3 
and is selectively degraded by autophagy (Pankiv et al., 2007). We found a direct interaction 
between TRIM32 and the SLRs p62 and NDP52, and we found the protein levels of all five 
SLRs to be modified by TRIM32WT and the BBS11 mutant, but not by the LGMD2H disease 




induced in the TRIM32 KO cells reconstituted with TRIM32WT and TRIM32P130S. 
TRIM32D487N, however, was not able to rescue the p62 dot formation. Notably, inhibition of 
autophagosome degradation also increases the amount of LC3-II and p62 (Bjorkoy et al., 2005; 
Tanida et al., 2005). Furthermore, LC3-II can localize on non-autophagy structures that are not 
turned over in the lysosome, particularly if overexpressed by transient transfection or if 
aggregates are formed in the cells (Kuma et al., 2007). Therefore, the amount of LC3-II and 
p62 at any given time does not necessarily represent the degradation of autophagosomes. To 
distinguish whether autophagosome accumulation is due to autophagy induction or inhibition 
of degradation, autophagic flux assays can be performed (Mizushima et al., 2010). We looked 
at the autophagic flux by looking at the protein levels of the SLRs and LC3B in TRIM32 KO 
cells and TRIM32 KO cells reconstituted with TRIM32 wild type and disease mutants. The 
levels of the SLRs are reduced in the cells reconstituted with E3 ligase active TRIM32. Thus, 
E3 ligase activity of TRIM32 seems to be important for autophagic degradation of SLRs and 
for p62 dot formation, either through phase separation or through sequestration.  
 TRIF is an adaptor protein that promotes inflammatory mediators and activation of 
antimicrobial responses, and it is essential for TLR3- and TLR4- mediated signaling pathways 
(Ullah et al., 2016; Yamamoto et al., 2003). TRIF leads to activation of IRF3 through TBK1 
and it is involved in the NF-B activation pathway through recruitment of receptor-interacting 
protein 1 (RIP1) (Liu et al., 2015; Meylan et al., 2004). TRIM32 is involved in the autophagic 
degradation of TRIF, and knockdown of LC3B inhibited TRIM32-mediated degradation of 
TRIF. Furthermore, overexpression of TRIM32 enhanced the interaction of LC3B with TRIF 
(Yang et al., 2017). These results suggest that TRIM32 mediates degradation by the autophagy-
lysosome pathway, further supporting our results that TRIM32 facilitates selective autophagy. 
However, we could not detect a strong and reproducible effect on LC3B lipidation in the 
TRIM32 KO and reconstituted cells, suggesting that TRIM32 has a role in SLR mediated 
selective autophagy, and not global autophagy as such. 
We found that the disease mutant TRIM32D487N is not an autophagy substrate, 
suggesting dependence on it oligomerization and/or auto-mono-ubiquitylation abilities to be 
recognized as an autophagic substrate. This is in contrast to a recent report showing BafA1 
mediated stabilization of a TRIM32 LGMD2H mutant in primary myoblasts isolated from a 
patient (Servian-Morilla et al., 2019). This discrepancy may be explained by the different cell 
systems, as we used HEK 293 cells, HeLa cells and C2C12 cells, while Servian-Morilla et al. 




  TRIM32 is a regulator of ULK1 activity in atrophic muscle cells, and the regulation is 
dependent on the E3 ligase activity of TRIM32 and on AMBRA1 (Di Rienzo et al., 2019). 
AMBRA1, interacting with the E3 ligase TRAF6, ubiquitylates ULK1 with K63-linked 
ubiquitin chains (Nazio et al., 2013). We immunoprecipitated ULK1 with TRIM32WT and 
mutants to detect whether TRIM32 regulate ULK1 through ubiquitylation. However, we could 
not detect any ubiquitylation of ULK1. This is in line with the work of Di Rienzo et al. (2019), 
where they found that ULK1 is not a direct substrate of TRIM32. We found that ULK1 is 
stabilized in cells expressing E3 ligase active TRIM32, but not in cells expressing the LGMD2H 
disease mutant. The stabilization of ULK1 is required for starvation-induced autophagy. 
Stabilization of ULK1 is achieved through post- translational modifications, such as 
ubiquitination, phosphorylation and dephosphorylation of specific sites (Xie et al., 2015b). 
Thus, TRIM32 may have a role in the post- translational modifications of ULK1, such as by 
regulating ULK1 modifiers.   
 
Ubiquitylation of p62 
The PB1 domain of p62 oligomerize in a front to back fashion, driving the formation of helical 
filaments (Ciuffa et al., 2015). Dimerization and ubiquitylation of p62 is incompatible with 
each other because the dimer occludes the ubiquitin binding sites (Isogai et al., 2011; Long et 
al., 2010). Peng et al. (2017) identified two E2 conjugation enzymes, UBE2D2 and UBE2D3, 
which interacts directly with p62 via the EIR region and mediates ubiquitylation at several 
lysine residues, among them K157, K295 and K420. This polyubiquitylation is thought to 
relieve the inhibition of the UBA domain in the p62 UBA dimer, leading to enhanced binding 
and tethering of ubiquitylated cargo to the ATG8s conjugated to the phagophore (Conway and 
Kirkin, 2017). In our studies we identified by MS that TRIM32WT and the BBS11 disease 
mutant TRIM32P130S ubiquitylate p62 at K157 and K295. Ubiquitylation assays showed that 
TRIM32 may mono-ubiquitylate p62 on several residues, enhancing p62 body formation and 
p62- mediated autophagic activity. We were not able to map the exact lysine ubiquitylated by 
TRIM32, which indicates that multiple lysine residues may be potential targets of TRIM32. 
Another possibility is that another lysine than those we looked at is modified by TRIM32. 
Furthermore, we found that the LGMD2H disease mutants were unable to mono-ubiquitylate 
p62. Interestingly, the interaction with p62 was not inhibited. Other studies have found that 
LGMD2H mutations impair the interaction between TRIM32 and Piasy and ULK1 (Albor et 




the binding sites for Piasy and ULK1. Furthermore, the interaction between TRIM32 and ULK1 
and Piasy may depend on the E3 ligase activity of TRIM32, while the interaction with p62 does 
not. 
 In our studies we see mono-ubiquitylation of p62. Most studies find that TRIM32 poly-
ubiquitylates its substrates (Di Rienzo et al., 2019; Nicklas et al., 2012; Streich et al., 2013). 
However, one study report TRIM32 to both mono- and poly-ubiquitylate Piasy (Albor et al., 
2006). Hence, while it is not common for TRIM32 to mono-ubiquitylate its substrates it has 
been reported previously. Further studies should look at the differences between the mono- and 
poly-ubiquitylation conducted by TRIM32. Peng et al. (2017) looked at the ubiquitylation of 
p62 and found that p62 is ubiquitylated upon autophagy activation. They found that heat-shock 
treatment led to elevated levels of polyubiquitylated conjugates. It would be interesting to study 
at the difference between mono- and poly-ubiquitylated p62 and their role in autophagy.   
 There is also the possibility that ubiquitylated p62 creates high-complexity scaffolds 
(Conway and Kirkin, 2017). K63- polyubiquitin chains, but not monoubiquitin, can induce p62 
phase separation. Furthermore, p62 polymerization and the interaction between p62 and 
polyubiquitin chains through the UBA domain are important for the p62 phase separation (Sun 
et al., 2018). Even though Sun et al. (2018) found that mono-ubiquitylation of p62 does not 
induce phase separation of p62, the combinations of different post-translational modifications 
will likely have impact on p62 functions, among them autophagy.  
The p62 K157 site is evolutionary conserved and localized in the zinc finger domain. 
Vault RNA1-1 bind to the ZZ domain and modulate its dimerization and autophagic activity 
(Horos et al., 2019). RIP, a TNFα signaling adaptor, also binds to the ZZ domain and this 
interaction serves to link the atypical protein kinase C (aPKC) to activation of NF-B (Sanz et 
al., 1999). Hence, post-translational modification of the ZZ domain could regulate such 
interactions, and this would be interesting to study in further works.  
 The p62 K295 site lies at the border of the EIR domain and a previously predicted PEST 
domain, and adjacent to the LIR domain. The PEST sequence serves as a proteolytic signal for 
rapid degradation, leading to short intracellular half-lives (Liu et al., 2016b). Thus, disruption 
of these sites may possibly impact the ability of p62 to bind to the ATG8 proteins, it could 
regulate the interaction with E2 enzymes and it could prevent degradation of p62 and thereby 
have impact on p62 stability.  





TRIM32 and mitophagy 
We found that TRIM32 directly interacted with and colocalized with NDP52. Studies have 
demonstrated that NDP52 plays an important role in selective degradation of depolarized 
mitochondria (Heo et al., 2015; Lazarou et al., 2015; Vargas et al., 2019). Tethering of NDP52 
to the mitochondria recruited the ULK1 complex via FIP200. We induced mitophagy by 
overexpression of FKBP8 and LC3A, and mitophagy was measured using the double- tagged 
mCherry-GFP-OMP25TM (Bhujabal et al., 2017). We observed a reduction in mitophagy in 
the TRIM32 KO cells compared to the normal HEK293 cells. Importantly, reintroduction of 
TRIM32 to the TRIM32 KO cells restored the mitophagy activity.  
TBK1 recruits NDP52 to the mitochondria and facilitates the association of NDP52 with 
the ULK1 complex (Heo et al., 2015; Vargas et al., 2019). Enrichment of TBK1 on the 
mitochondrial membrane induces TBK1 S172 autophosphorylation (Kishore et al., 2002; Ma 
et al., 2012).  When we assessed the TBK1 S172 phosphorylation in TRIM32 KO and 
reconstituted cell lines we found that the amount of S172 phosphorylated TBK1 is highly 
upregulated in the TRIM32 KO cell lines reconstituted with TRIM32, compared to the TRIM32 
KO cells. This suggest that TRIM32 may facilitate TBK1 recruitment to the mitochondrial 
membrane, and thereby activation which is important for efficient mitophagy. TRIM32 has 
been reported to be localized at the mitochondria and ER, which further strengthen the 
possibility that TRIM32 has a role in mitophagy (Zhang et al., 2012). Furthermore, TRIM32 
interacts with AMBRA1, and AMBRA1 is known to promote mitophagy with PARKIN and 
HUWE1 (Di Rienzo et al., 2019; Di Rita et al., 2018; Van Humbeeck et al., 2011). 
An important question for further studies is whether the TRIM32 mediated 
ubiquitylation of NDP52 directly facilitates its role as a receptor in selective autophagy, such 
as mitophagy. 
 
Pathological mechanisms of LGMD2H  
Muscle growth occurs during development and in response to mechanical overload and anabolic 
hormonal stimulation. During development, the muscle growth depends on protein and cellular 
development. Ubiquitin signaling and the autophagy-lysosome pathway are important quality 
control mechanisms for muscle proteins. Muscle atrophy involves the shrinkage of myofibrils 
due to a net loss of proteins, organelles and cytoplasm, and the protein degradation exceeds the 
protein synthesis. UPS and autophagy are activated during muscle atrophy (Sandri, 2013). Vici 
syndrome is a muscle dystrophy that is associated with defective autophagy through a mutation 




Four of the TRIM32 LGMD2H mutations, R394H, D487N, D588del and T520TfsX13, 
are shown to be unable to self-interact (Saccone et al., 2008). The remaining LGMD2H 
mutations were not identified yet at the time of the study conducted by Saccone et al. (2008), 
and were therefore not included. In our study, we show that the LGMD2H mutants, but not the 
BBS11 mutant, are unable to self-ubiquitylate as well. This is supported by a study showing 
that the TRIM32 LGMD2H mutants D487N and R394H have impaired E3 ligase activity and 
is unable to ubiquitylate dysbindin (Locke et al., 2009). Interestingly, TRIM32 dimerize 
through the RING domain, and this dimerization is crucial for the catalytic activity 
(Koliopoulos et al., 2016). Thus, the impaired oligomerization and ubiquitylation properties 
may be important for the development of LGMD2H.  
The molecular mechanisms of the TRIM32 mutants causing LGMD2H and BBS11 are 
far from understood. We show that the LGMD2H disease mutant of TRIM32 is unable to mono-
ubiquitylate p62. The mutations responsible for LGMD2H is localized in the NHL domain, and 
they do not inhibit the binding of TRIM32 to p62. Previous studies have reported that the 
LGMD2H mutants display a more diffuse cytoplasmic localization than TRIM32WT and 
TRIM32P130S, which are enriched in puncta in most cells (Locke et al., 2009). Furthermore, 
knock in mice carrying the mutation in murine TRIM32 corresponding to the human D487N 
mutation had normal mRNA levels of TRIM32 but a severe reduction in mutant TRIM32 at the 
protein level (Kudryashova et al., 2011). Supporting this, the LGMD2H mutations seems to 
lead to reduced TRIM32 protein levels in muscle samples from LGMD2H patients (Servian-
Morilla et al., 2019). It is known that the self-ubiquitylation of TRIM32 is important for its 
activation. We show that this mono-ubiquitylation may be important for degradation of 
TRIM32 through selective autophagy. TRIM32 has been shown in several reports to 
ubiquitylate proteins whose deregulation might influence the onset and progression of muscular 
dystrophy, including actin, tropomycin, troponins, α-actinin, dysbindin and c-Myc (Tocchini 
and Ciosk, 2015). Interestingly, p62 is strongly implicated in Chaperone-assisted selective 
autophagy (CASA), which is essential for muscle maintenance (Arndt et al., 2010). We found 
that the LGMD2H mutations results in an accumulation of the SLRs and reduced autophagic 
activity of p62 and NDP52. Reduced autophagic activity may lead to accumulation of 
aggregates. Interestingly, a study looking at biopsies from LGMD2H patients found an increase 
of cytoplasmic bodies in the muscle cells (Servian-Morilla et al., 2019), which may be caused 
by decreased autophagic activity. Hence, LGMD2H may be due to dysfunctional selective 






TRIM27 as a regulator of xenophagy 
TRIM27 belongs to the same TRIM family subclass as TRIM5α, which has been shown to act 
as a selective autophagic receptor, targeting a restricted virus to the autophagosomes for 
degradation (Mandell et al., 2014a). They demonstrated that TRIM5α interacts directly with 
ATG8s via a LIR motif. Here, we identified a putative LIR in the coiled coil region of TRIM27. 
However, TRIM27 does not undergo autophagic degradation in the absence of the SLRs and is 
therefore not an autophagic receptor, but rather an autophagic substrate.  
Xenophagy is the cells defense mechanism against invading pathogens. Damage to the 
phagophore containing pathogens expose glycans to cytosol. These glycans attract Gal8, which 
is recognized by NDP52 (Thurston et al., 2012). NDP52 then recruits NAP1, similar to NAP1 
TBK1 adaptor (SINTBAD), TBK1 and LC3C (Shpilka and Elazar, 2012; von Muhlinen et al., 
2012). All of the SLRs have a LIR domain and interacts with ATG8 proteins, but the bindings 
are selective. LC3C is the only ATG8 that interacts with NDP52 and has a specific role in 
xenophagy (von Muhlinen et al., 2012). In absence of LC3C, the remaining ATG8 orthologues 
are unable to support efficient antibacterial autophagy. We found that TRIM27 interacts with 
LC3C, GABARAP and GABARAPL1, but not to the other ATG8 proteins. When the LIR 
region was mutated, we got a strong reduction in the binding to LC3C, and some reduction in 
the binding to GABARAP and GABARAPL1. Furthermore, TRIM27 regulates innate immune 
response by interacting with and mediating K48-linked ubiquitylation of NOD2 (Zurek et al., 
2012). Together these results propose that TRIM27 could have a role in xenophagy, 
representing a link between innate immunity and selective autophagy. 
 By looking at the TRIM27 KO cells we found that the starvation-induced degradation 
of p62 and LC3B is abolished when the cells are stressed by plasmid transfection. TRIM27 
interacts with USP7, which has been shown to inhibit the RNA virus mimic poly I:C- mediated 
IFN-stimulated response element (ISRE) and IFN-β activation (Cai et al., 2018). We infected 
the TRIM27 KO cells with poly AT that mimics DNA virus infection and observed inhibition 
of the starvation-induced degradation of p62. These results further supports that TRIM27 may 
have a regulatory effect on autophagy induction under immune stress conditions.   
 
TRIM27, a potential prognostic marker linked to autophagy 
Initially, TRIM27 was identified as a gene involved in oncogenic rearrangement with the RET 




cells to display enhanced cell proliferation, suggesting that TRIM27 is an inhibitor of cell 
proliferation. However, it was recently found that knock down of TRIM27 in colorectal cancer 
cells significantly inhibits proliferation (Zhang et al., 2018c). The observed discrepancy may 
be due to the different cell lines used. We also found that TRIM27 facilitate cell migration, 
which is in agreement with previous studies (Lv et al., 2016; Zhang et al., 2018c). 
 Epithelial-to-mesenchymal transition (EMT) occur naturally during development and 
tissue repair, but it is also recognized as the event where cancer cells acquire an invasive 
phenotype by promoting invasion and metastasis (Colella et al., 2019; Li and Li, 2015). EMT 
involves multiple mechanisms, and among them is the activation of the phosphorylated 
serine/threonine kinase AKT (p-AKT). There is a complex cross-talk between autophagy and 
EMT (Colella et al., 2019). Autophagy can modulate EMT through selective degradation of 
EMT players (Lv et al., 2012). The effect of autophagy on EMT seems to depend on the cell 
type and the stimulus employed for activating or inhibiting autophagy (Colella et al., 2019). 
Our proliferation and migration studies suggest that TRIM27 may be implicated in EMT. This 
is in line with a recent study which found that TRIM27 promotes EMT and activation of p-
AKT (Zhang et al., 2018c).  
TRIM27 is upregulated in cancer tissue from various cancers, including breast (Tezel et 
al., 2009), lung (Iwakoshi et al., 2012), ovarian (Horio et al., 2012; Ma et al., 2016) and 
endometrial (Tsukamoto et al., 2009), compared to normal tissue. Upregulated TRIM27 in 
breast cancer has been linked to its nuclear role implicated in estrogen receptor transcription 
complexes, and associated with human epidermal growth factor receptor 2 (HER2) status (Tezel 
et al., 2009; Townson et al., 2006). We used bioinformatics tools to analyze TRIM27 mRNA 
expression in cancer tissue and normal tissue from breast cancer patients, and found that 
TRIM27 mRNA was significantly upregulated in cancer tissue compared to normal tissue. 
Interestingly, TRIM27 expression varies substantially within the various breast cancer 
subtypes, and so does LC3B. Notably, the expression of TRIM27 and LC3B seemed somehow 
inversely correlated in these cell lines. This is in line with our observation of LC3B in the 
TRIM27 KO cells, where LC3B seemed to be stabilized. Thus, TRIM27 may impact autophagy 
in breast cancer cells via regulation of the LC3B expression levels. This is an important 









We have used the double- tagged mCherry-EYFP system for identification of TRIM proteins 
that are substrates for autophagic degradation. This is an overexpression assay, thus we cannot 
be certain that the endogenous proteins behave in the same manner. Furthermore, we only used 
an N-terminal mCherry-EYFP tag, and therefore there is a possibility that the tag may have 
influenced the ability of some proteins to be degraded by autophagy. However, many of the 
TRIM proteins that were identified as autophagic substrates in our screen are previously shown 
to have a role in autophagy (Chauhan et al., 2016; Kimura et al., 2015; Mandell et al., 2014a). 
This indicates that the double-tag assay function well as a screening method for identifying 
TRIM proteins implicated with autophagy.  
We have used the CRISPR/Cas9 technology to generate knock out cell lines (Ran et al., 
2013). We made specific guide RNA sequences targeting the gene of interest early in exon 1 
using the bioinformatics tools made by the Feng Zhang group (Ran et al., 2013), and cloned 
them into a plasmid expressing Cas9. The Cas9 makes double-stranded DNA cut after 
recognition of the protospacer adjacent motif (PAM) sequence and binding of guide RNA with 
its specific target gene sequence. The guide RNA is normally 21 nucleotides long and can 
potentially bind to non-target genes leading to off-target effects (Fu et al., 2013). Off-target 
mutations may be due to non-specific nuclease activity, leading to mutations in regions other 
than the target. Fu et al. (2013) detected off-target alterations induced by four out of six CRISPR 
RNA guided endonucleases. Many of the off-target sites are mutagenized with frequencies 
comparable to the intended on-target site (Fu et al., 2013). Off- target mutations may cause 
genomic instability and disrupt the functionality of otherwise normal genes (Gupta et al., 2019; 
Zhang et al., 2015). To reduce the off-target effects, a mutant form of Cas9 have been 
developed. This mutant Cas9 makes single-stranded DNA nicks and requires binding of two 
guide RNA target sequences for generating a staggered double-stranded DNA cut (Ran et al., 
2013). This increases the specificity of the CRISPR/Cas9 method. Initially we tried making KO 
cells by this method, however, we did not get any surviving clones. Therefore, our KO cells are 
made by the double-stranded DNA cut, and thus we cannot rule out the possibility for off-target 
effects. There is continuous ongoing work to improve the CRISPR/Cas9 method and reduce the 
off-target effects. Methods to identify if the phenotype in the KO is due to knock out of the 
gene of interest, or an off target effect, are i) to validate the phenotype in more than one KO 
clone, ii) to re-introduce the KO gene into the KO clone and verify that the phenotype is 




sequencing, or sequence the regions of the genome that have closest similarity to the guideRNA 
and therefore is most exposed to off-target effects. We verified the KO cell lines by i and ii of 
the aforementioned methods.  
CRISPR/Cas9 cell lines are established from only one cell. However, the cells within a 
cell line differs in rate of protein expression and metabolic activity. One should therefore be 
aware of that the differences observed in protein expression may be due to clonal effects and 
not the KO phenotype. This can be verified by analyzing more than one KO clone, and to 
compare the phenotypes of the KO clones with the phenotype obtained when the gene of interest 
is knocked down by siRNA in the mother cell line.   
 The FlpIn T-REX system was used for generating cell lines with stably expressing 
TRIM32 and TRIM32 mutants. This system is based on the tetracycline-inducible expression 
of the gene of interest. An expression level similar to wild type is hard to obtain, therefore the 
expression level of the proteins in this system is commonly not at the same level as endogenous. 
The gene expression may be regulated by titrating tetracycline, but it is difficult to achieve the 
exogenous protein level. Our cell lines stably expressing TRIM32 and TRIM32 mutants have 
a background of endogenous protein, which may influence the phenotypes of the mutants as 
TRIM proteins have a tendency to dimerize. Furthermore, the gene of interest is not under 
control of the endogenous promoter, but a CMV promoter in the FlpIn system. Hence, a main 
drawback of the stable cell lines is that their expression is not at the same level as the 
endogenous protein and that they are not regulated in the same way as the endogenous protein.  
However, we got similar results by using the reconstituted KO cells as the stable cell lines. 
Notably, the reintroduced TRIM32 proteins in the KO cells were also over-expressed compared 
to endogenous protein level. Thus, our results obtained in the KO and reconstituted KO cells 
do not necessarily reflect the endogenous situation, but we believe that they gave some 
information on the roles of these TRIMs in autophagy.  
 In the ubiquitylation assay we over-expressed TRIM32 and p62/NDP52 in cells. Hence, 
we cannot rule out that the ubiquitylation is only due to over-expression of TRIM32. In our 
initial ubiquitylation experiments we also co-overexpressed ubiquitin. However, we noticed 
that over-expression of ubiquitin alone induced ubiquitylation of p62. This is in accordance 
with previous studies, which have found that overexpression of ubiquitin activates autophagy 
in a p62-dependent manner (Peng et al., 2017). Therefore, we have analyzed TRIM32- mediated 
ubiquitylation of the SLRs without ubiquitin overexpression, which we believe reflects more 
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